Nominations for the 2014 award are now closed.
The 2014 award recipient will be announced January 2014.
The Award and Lecture
The prestigious Pezcoller Foundation–AACR International Award for Cancer Research was established in 1997 to annually recognize a scientist of international renown:
- who has made a major scientific discovery in basic cancer research OR who has made significant contributions to translational cancer research;
- who continues to be active in cancer research and has a record of recent, noteworthy publications; and
- whose ongoing work holds promise for continued substantive contributions to progress in the field of cancer.
The award is intended to honor an individual scientist. However, more than one scientist may be co-nominated and selected to share the award when their investigations are closely related in subject matter and have resulted in work that is worthy of the award.
The award consists of an unrestricted honorarium of €75,000, commemorative plaque, and full support to the winner and a guest to attend the AACR Annual Meeting. The winner of the 17th Annual Pezcoller Foundation-AACR International Award for Cancer Research will give a 50-minute award lecture at the AACR Annual Meeting 2014 in San Diego, CA, U.S.A. (April 5-9, 2014).
- Eligible candidates are cancer researchers affiliated with institutions in academia, industry, or government that are involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world.
- Institutions or organizations are not eligible for the award.
- Receipt of other major awards does not preclude a candidate from eligibility for the award.
- No regard shall be given to race, gender, nationality, geographic location, or religious or political views.
Nomination Procedure and Instructions
Nominations are closed.
Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.
Nominations must be submitted online at https://proposalcentral.altum.com, no later than 4:00 p.m. United States Eastern Time on Thursday, September 12, 2013. Paper nominations will not be accepted. Full nomination instructions and program guidelines are available through the link below and on the proposalCENTRAL website.
Candidates for the award will be considered by a prestigious international Selection Committee of renowned cancer leaders appointed by the president of the AACR in consultation with the Council of the Pezcoller Foundation. The committee will consider all nominations as they have been submitted; the committee may not combine submitted nominations, add a new candidate to a submitted nomination, or otherwise make alterations to the submitted nominations. After careful deliberations by the committee, its recommendations will be forwarded to the Executive Committee of the AACR and the Council of the Pezcoller Foundation for final consideration and determination.
Selection of the award winner will be made on the basis of the candidate's scientific accomplishments. No regard will be given to race, gender, nationality, or religious or political view.
Responsibilities of the Award Recipient
The winner will also present the Ninth Annual Stanley J. Korsmeyer Lecturein Padua, Italy, just prior to the official award ceremony in Trento, Italy, in May 2014. Remarks to be made during the ceremony must be delivered to the Pezcoller Foundation at least four weeks prior to allow sufficient time for translation into Italian. Should the winner be unable to participate in either event, the award must be forfeited and may be presented instead to the alternate.
In the rare event that there are dual winners of the award, the cash award will be shared equally between them, and the AACR Executive Committee will determine which of the two co-recipients will present the Pezcoller-AACR Award Lecture at the AACR Annual Meeting.
The Stanley J. Korsmeyer Lecture
This lectureship has been created through the Pezcoller Foundation, the Venetian Institute of Molecular Medicine, and the AACR to honor the late Dr. Stanley J. Korsmeyer's outstanding and significant contributions to our understanding of the mechanisms that regulate programmed cell death and survival.
Dr. Korsmeyer’s numerous accomplishments in the cancer field led to his being named the recipient of the Pezcoller Foundation-AACR International Award for Cancer Research in 2004. He subsequently presented a lecture at the Venetian Institute of Molecular Medicine – his last European lecture before his untimely death from cancer in 2005.
Through this lectureship, the Foundation, the Institute and the AACR wish to remember Dr. Korsmeyer in the manner he would have liked best – with the presentation of significant science and discussion among colleagues in cancer research. The lecture will be presented annually by the recipient of the Pezcoller-AACR Award, and will be delivered each year in May at the Venetian Institute of Molecular Medicine in Padua, Italy.
The Pezcoller Foundation was established in 1980 by Professor Alessio Pezcoller, a dedicated Italian surgeon who made important contributions to medicine during his career and who, through his foresight, vision, and generous gift in support of the formation of the foundation, stimulated others to join this effort in sustaining the work of the foundation. Professor Pezcoller has inspired scientists around the world to make significant advances in cancer research. In addition to sponsoring this prestigious award, the foundation also sponsors a series of symposia, publishes a journal, and supports awards for early-career scientists from Europe who have submitted highly rated abstracts for presentation at the AACR Annual Meeting.
Linda Stokes, Program Associate
American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404
16th Annual Recipient
Peter K. Vogt, Ph.D.
Department of Molecular & Experimental Medicine
The Scripps Research Institute
La Jolla, CA
Dr. Peter K. Vogt delivered his award lecture titled PI3K - From Simplicity to Complexity and Back, at the AACR Annual Meeting 2013 in Washington, D.C. The award ceremony and lecture were held on Monday, April 8, 2013. Visit the AACR Annual Meeting 2013 page for more information on the Annual Meeting.
Dr. Peter K. Vogt was honored for his efforts to further understand the causes of cancer. His discovery that the Rous Sarcoma Virus (RSV) causes cancer through the activity of a single gene was a turning point in cancer research, and one that has greatly contributed to our current understanding of cancer's genetic mechanisms.
Dr. Vogt has spent his entire career in cancer research, much of it focused on studying cancer-causing viruses. In 1970, he published his seminal work on the genetic basis of the cancer-causing capability of the RSV. He subsequently made several further pioneering discoveries, including the identification of several genes that are important in driving human cancers: MYC, JUN and PI3K. His more recent studies have led to the ongoing clinical development of numerous agents designed to target cancer-causing mutations in PI3K.
Dr. Vogt received his doctorate from the University of Tübingen in Germany, and completed postdoctoral training at the University of California, Berkeley, before becoming associate professor of pathology at the University of Colorado School of Medicine in Denver. He then served as professor of microbiology at the University of Washington School of Medicine in Seattle, and then as the Hastings distinguished professor of microbiology and chairman of the Department of Microbiology at the University of Southern California School of Medicine in Los Angeles before moving to The Scripps Research Institute.
Numerous accolades have been awarded to Dr. Vogt, including the California Scientist of the Year Award (1975), the Ernst Jung Prize for Medicine (1985), the Robert J. and Claire Pasarow Award (1987), the Bristol Myers Award (1989), the ICN International Prize in Virology (1989), the Charles S. Mott Prize from the General Motors Cancer Research Foundation (1991), the Gregor Johann Mendel Medal from the National Academy of the Sciences of the Czech Republic (2008) and the Albert Szent-Györgyi Prize for Progress in Cancer Research (2010).